These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2828746)

  • 21. Kininases and vascular responses to kinins.
    Babiuk C; Marceau F; St-Pierre S; Regoli D
    Eur J Pharmacol; 1982 Feb; 78(2):167-74. PubMed ID: 6122586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in the kinin levels in the bronchial washings after intravenous injection of leukotriene C4 in guinea pigs.
    Majima M; Jin HY; Katori M; Sunahara N
    Agents Actions Suppl; 1992; 38 ( Pt 3)():467-74. PubMed ID: 1462880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of renal kininases in patients with primary aldosteronism.
    Ura N; Shimamoto K; Nomura N; Iwata M; Aoyama T; Takagawa Y; Iimura O
    Clin Exp Hypertens; 1995 Oct; 17(7):1049-58. PubMed ID: 8556003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in normotensive and hypertensive rats.
    Nomura N; Shimamoto K; Ura N; Iwata M; Aoyama T; Takagawa Y; Iimura O
    Clin Exp Hypertens; 1995 Nov; 17(8):1219-31. PubMed ID: 8563698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary excretions of kininase I and kininase II activities in essential hypertension. A sensitive and simple method for its kinin-destroying capacity.
    Ura N; Shimamoto K; Tanaka S; Nishimiya T; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Iimura O
    J Clin Hypertens; 1985 Mar; 1(1):15-22. PubMed ID: 3014073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo.
    Ichinose M; Barnes PJ
    Br J Pharmacol; 1990 Sep; 101(1):77-80. PubMed ID: 2282470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kininase II-type enzymes. Their putative role in muscle energy metabolism.
    Dragović T; Minshall R; Jackman HL; Wang LX; Erdös EG
    Diabetes; 1996 Jan; 45 Suppl 1():S34-7. PubMed ID: 8529798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of urinary alkalinization on the intrarenal formation of kinins.
    Brukman J; Murray RD; Churchill PC; Scicli AG; Carretero OA
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F827-31. PubMed ID: 3000190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of kininases in testicular cells.
    Monsees TK; Miska W; Schill WB
    Immunopharmacology; 1996 May; 32(1-3):169-71. PubMed ID: 8796300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinin stimulation of renin release in isolated rat glomeruli.
    Beierwaltes WH; Prada J; Carretero OA
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F757-61. PubMed ID: 2988345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanisms of the renal effects of neutral endopeptidase inhibitor in rats.
    Ura N; Shimamoto K; Nomura N; Aoyama T; Iwata M; Takagawa Y; Iimura O
    Clin Exp Hypertens; 1995 Nov; 17(8):1183-96. PubMed ID: 8563696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
    Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of kinin degradation on the luminal side of renal tubules reduces high blood pressure in deoxycorticosterone acetate salt-treated rats.
    Nakajima S; Ito H; Hayashi I; Kuribayashi Y; Okumura T; Yajima Y; Katori M; Majima M
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):80-7. PubMed ID: 10696533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
    Filep J; Rigter B; Földes-Filep E
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal effects of Fab fragments of kinin antibodies on deoxycorticosterone acetate-salt-treated rats.
    Tomiyama H; Scicli AG; Scicli GM; Carretero OA
    Hypertension; 1990 Jun; 15(6 Pt 2):761-6. PubMed ID: 2351428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of renal kininases in patients with Cushing's syndrome.
    Shimamoto K; Ura N; Nomura N; Aoyama T; Iwata M; Takagawa Y; Iimura O
    Clin Exp Hypertens; 1995 Nov; 17(8):1173-82. PubMed ID: 8563695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some old and some new ideas on kinin metabolism.
    Erdös EG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S20-4. PubMed ID: 1697356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological role of renal kallikrein-kinin system in human.
    Shimamoto K; Iimura O
    Adv Exp Med Biol; 1989; 247A():87-96. PubMed ID: 2557757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.